↓ Direkt till sidans innehåll
↓ Direkt till sidans sekundära innehåll (sidomenyn)

Träfflista för sökning "WFRF:(Mohty M) "

Search: WFRF:(Mohty M)

Result 51-60 of 95

Sort/group result

Sort by: Hits per page:

Enumeration	Reference	Cover	Find
51.	Bazarbachi, A, et al. (author) Comparable outcomes of haploidentical transplant with TBF conditioning versus matched unrelated donor with fludarabine/busulfan conditioning for acute myeloid leukemia 2021 In: Bone marrow transplantation. - : Springer Science and Business Media LLC. - 1476-5365 .- 0268-3369. ; 56:3, s. 622-634 Journal article (peer-reviewed)
52.	Brands-Nijenhuis, AVM, et al. (author) Monosomal karyotype as an adverse prognostic factor in patients with acute myeloid leukemia treated with allogeneic hematopoietic stem-cell transplantation in first complete remission: a retrospective survey on behalf of the ALWP of the EBMT 2016 In: Haematologica. - : Ferrata Storti Foundation (Haematologica). - 1592-8721 .- 0390-6078. ; 101:2, s. 248-255 Journal article (peer-reviewed)
53.	Cesaro, S, et al. (author) Incidence, Risk Factors, and Long-term Outcome of Acute Leukemia Patients With Early Candidemia After Allogeneic Stem Cell Transplantation: A Study by the Acute Leukemia and Infectious Diseases Working Parties of European Society for Blood and Marrow Transplantation 2018 In: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. - : Oxford University Press (OUP). - 1537-6591. ; 67:4, s. 564-572 Journal article (peer-reviewed)
54.	Chevallier, P, et al. (author) Impact of cytogenetics risk on outcome after reduced intensity conditioning allo-SCT from an HLA-identical sibling for patients with AML in first CR: a report from the acute leukemia working party of EBMT 2012 In: Bone Marrow Transplantation. - : Nature Publishing Group. - 0268-3369 .- 1476-5365. ; 47:11, s. 1442-1447 Journal article (peer-reviewed)abstract So far the impact of cytogenetics risk on outcome in the context of reduced intensity conditioning (RIC) allo-SCT has been poorly studied. We have identified 378 AML patients in first CR who underwent RIC allo-SCT from an HLA-matched sibling donor between 2000 and 2007 reported to the European Group for Bone and Marrow Transplantation and for whom detailed cytogenetics data were available (good risk: n = 21; intermediate risk: n = 304; and poor risk: n = 53). With a median follow-up of 24 months (range: 1-93), 2-year non-relapse mortality, relapse rate (RR), leukemia-free survival (LFS) and OS were 14%, 31%, 55% and 61%, respectively. Cytogenetics was significantly associated with RR (good risk: 10%; intermediate risk: 28%; and poor risk: 55% at 2 years, Pandlt;0.0001) and LFS (good risk: 64%; intermediate risk: 57%; and poor risk: 38% at 2 years, P = 0.003). In a multivariate analysis, RR and LFS were significantly higher and lower, respectively, in the high-risk cytogenetics group (P = 0.001, P = 0.004) and in patients with a higher WBC at diagnosis (andgt;10 x 10(9)/L) (Pandlt;0.001, P = 0.004). As documented in the setting of myeloablative allo-SCT, patients with poor cytogenetics had increased RR and decreased LFS after RIC allo-SCT, requiring new prospective strategies to improve results in this subgroup.
55.	Chevallier, P, et al. (author) Outcome after allogeneic transplantation for adult acute myeloid leukemia patients exhibiting isolated or associated trisomy 8 chromosomal abnormality: a survey on behalf of the ALWP of the EBMT 2009 In: Bone marrow transplantation. - : Springer Science and Business Media LLC. - 1476-5365 .- 0268-3369. ; 44:9, s. 589-594 Journal article (peer-reviewed)
56.	Gavriilaki, E, et al. (author) Comparative study of treosulfan plus Fludarabine (FT14) with busulfan plus Fludarabine (FB4) for acute myeloid leukemia in first or second complete remission: An analysis from the European Society for Blood and Marrow Transplantation (EBMT) Acute Leukemia Working Party (ALWP) 2022 In: Bone marrow transplantation. - : Springer Science and Business Media LLC. - 1476-5365 .- 0268-3369. ; 57:12, s. 1803-1809 Journal article (peer-reviewed)
57.	Gilleece, MH, et al. (author) Measurable residual disease, conditioning regimen intensity, and age predict outcome of allogeneic hematopoietic cell transplantation for acute myeloid leukemia in first remission: A registry analysis of 2292 patients by the Acute Leukemia Working Party European Society of Blood and Marrow Transplantation 2018 In: American journal of hematology. - : Wiley. - 1096-8652 .- 0361-8609. ; 93:9, s. 1142-1152 Journal article (peer-reviewed)
58.	Gratwohl, A, et al. (author) Economics and Outcome After Hematopoietic Stem Cell Transplantation: A Retrospective Cohort Study 2015 In: EBioMedicine. - : Elsevier BV. - 2352-3964. ; 2:12, s. 2101-2109 Journal article (peer-reviewed)
59.	Harris, AE, et al. (author) Pretransplant vaccinations in allogeneic stem cell transplantation donors and recipients: an often-missed opportunity for immunoprotection? 2015 In: Bone marrow transplantation. - : Springer Science and Business Media LLC. - 1476-5365 .- 0268-3369. ; 50:7, s. 899-903 Journal article (peer-reviewed)
60.	Ljungman, P, et al. (author) Correction: The challenge of COVID-19 and hematopoietic cell transplantation: EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapy 2021 In: Bone marrow transplantation. - : Springer Science and Business Media LLC. - 1476-5365 .- 0268-3369. ; 56:3, s. 755-755 Journal article (other academic/artistic)

Skapa referenser, mejla, bekava och länka

Permalink

Result 51-60 of 95

Refine your search

Type of publication: journal article (74); conference paper (20); research review (1)

Type of content: peer-reviewed (73); other academic/artistic (22)

Author/Editor: Mohty, M (88); Nagler, A (59); Labopin, M (56); Socie, G (35); Kroger, N (28); Ljungman, P (26); show more...; Blaise, D. (26); Mielke, S (24); Ciceri, F (23); Ringden, O (21); Yakoub-Agha, I (21); Giebel, S (18); Niederwieser, D (17); Finke, J. (16); Volin, L (14); Styczynski, J (14); Schmid, C. (13); Snowden, JA (13); Milpied, N (13); Rambaldi, A (13); Michallet, M (11); Rocha, V (11); Chevallier, P. (11); Craddock, C. (10); Basak, GW (10); Ehninger, G (10); Savani, BN (10); Corbacioglu, S (9); Spyridonidis, A (9); Savani, B (9); Cornelissen, JJ (9); Saccardi, R (8); Gedde-Dahl, T. (8); Forcade, E (8); Esteve, J (8); Kuball, J (8); Hamladji, RM (7); Aljurf, M (7); Cordonnier, C (7); Montoto, S (7); Iacobelli, S (7); de la Camara, R (7); Baron, F (7); Ruggeri, A (7); Stelljes, M (7); de Latour, RP (7); Sureda, A (7); Einsele, H (7); Huynh, A (7); Brissot, E (7); show less...

University: Karolinska Institutet (85); Linköping University (7); Lund University (3)

Language: English (95)

Research subject (UKÄ/SCB): Medical and Health Sciences (4); Social Sciences (1)

Year

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

Copyright © LIBRIS - National Library Systems
LIBRIS.kb.se

pil uppåt

Close

Copy and save the link in order to return to this view